Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene

Neoplasma

Volumn 53, Issue 6, 2006, Pages 478-484

  Pastorakova, A ^a   Hlubinova, K ^a   Altaner, C ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Apoptosis; Bacterial cytosine deaminase; Cancer gene therapy; Retroviral vector; Tumor necrosis factor alpha

Indexed keywords

BACTERIAL ENZYME; RETROVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER GENE THERAPY; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; ESCHERICHIA COLI CYTOSINE DEAMINASE SUICIDE GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PLASMID; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUICIDE GENE; TUMOR CELL;

EID: 33846366765     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. HUBER BE, AUSTIN EA, RICHARDS CA, DAVIS ST, GOOD SS. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 1994; 91: 8302-8306.
2. PEDERSON LC, VICKERS SM, BUCHSBAUM DJ, KANCHARLA SR, MAYO MS et al. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells. J Gastrointest Surg 1998; 2: 283-291.
3. XIE Y, GILBERT JD, KIM JH, FREYTAG SO. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Clin Cancer Res 1999; 5: 4224-4232.
4. LAMBIN P, NUYTS S, LANDUYT W, THEYS J, DE BE et al. The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminase. Int J Radiat Biol 2000; 76: 285-293.
5. KIEVIT E, NYATI MK, NG E, STEGMAN LD, PARSELS J et al. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts. Cancer Res 2000; 60: 6649-6655.
6. ANELLO R, COHEN S, ATKINSON G, HALL SJ. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation. J Urol 2000; 164: 2173-2177.
7. ROGULSKI KR, KIM JH, KIM SH, FREYTAG SO. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum Gene Ther 1997; 8: 73-85.
8. ROGULSKI KR, WING MS, PAIELLI DL, GILBERT JD, KIM JH et al. Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. Hum Gene Ther 2000; 11: 67-76.
9. ROGULSKI KR, ZHANG K, KOLOZSVARY A, KIM JH, FREYTAG SO. Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin Cancer Res 1997; 3: 2081-2088.
10. PASTORAKOVA A, HLUBINOVA K, BODO J, LIBBY J, RYCHLY B et al. Tumor targeted gene therapy with plasmid expressing human tumor necrosis factor alpha in vitro and in vivo. Neoplasma 2005; 52: 344-351.
11. BEUTLER B, VAN HC. Unraveling function in the TNF ligand and receptor families. Science 1994; 264: 667-668.
12. ROTHE J, GEHR G, LOETSCHER H, LESSLAUER W. Tumor necrosis factor receptors-structure and function. Immunol Res 1992; 11: 81-90.
13. SONG HY, REGNIER CH, KIRSCHNING CJ, GOEDDEL DV, ROTHE M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 1997; 94: 9792-9796.
14. WALLACH D, BOLDIN M, VARFOLOMEEV E, BEYAERT R, VANDENABEELE P et al. Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett 1997; 410: 96-106.
15. BRADHAM CA, QIAN T, STREETZ K, TRAUTWEIN C, BRENNER DA et al. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 1998; 18: 6353-6364.
16. DENG Y, REN X, YANG L, LIN Y, WU X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003; 115: 61-70.
17. FUKUMURA D, SALEHI HA, WITWER B, TUMA RF, MELDER RJ et al. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res 1995; 55: 4824-4829.
18. SCHMELZ K, WIEDER T, TAMM I, MULLER A, ESSMANN F et al. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. Oncogene 2004; 23: 6743-6759.
19. HLAVATY J, HLUBINOVA K, ALTANER C. Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene. Neoplasma 1999; 46: 267-276.
20. KALIBEROV SA, CHIZ S, KALIBEROVA LN, KRENDELCHTCHIKOVA V, DELLA MD et al. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity. Cancer Gene Ther 2006; 13: 203-214.
21. PASTORAKOVA A, HLUBINOVA K, JAKUBIKOVA J, ALTANER C. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene. Neoplasma 2006; 53: 353-362.
22. MORIUCHI S, OLIGINO T, KRISKY D, MARCONI P, FINK D et al. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase. Cancer Res 1998; 58: 5731-5737.
23. NIRANJAN A, MORIUCHI S, LUNSFORD LD, KONDZIOLKA D, FLICKINGER JC et al. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Mol Ther 2000; 2: 114-120.
24. NIRANJAN A, WOLFE D, TAMURA M, SOARES MK, KRISKY DM et al. Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery. Mol Ther 2003; 8: 530-542.
25. ZHANG JH, WAN MX, YUAN JY, PAN BR. Do there exist synergistic antitumor effects by coexpression of herpes simplex virus thymidine kinase with cytokine genes on human gastric cancer cell line SGC7901? World J Gastroenterol 2004; 10: 147-151.
26. OTSUKA G, NAGAYA T, SAITO K, MIZUNO M, YOSHIDA J et al. Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells. Cancer Res 1999; 59: 4446-4452.
27. CAI Z, KORNER M, TARANTINO N, CHOUAIB S. IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis. J Biol Chem 1997; 272: 96-101.
28. RATTER F, GASSNER C, SHATROV V, LEHMANN V. Modulation of tumor necrosis factor-alpha-mediated cytotoxicity by changes of the cellular methylation state: mechanism and in vivo relevance. Int Immunol 1999; 11: 519-527.